Free Trial

CollPlant Biotechnologies (CLGN) Competitors

CollPlant Biotechnologies logo
$2.62 +0.04 (+1.55%)
Closing price 09/17/2025 03:58 PM Eastern
Extended Trading
$2.67 +0.05 (+1.95%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLGN vs. BSGM, PROF, PDEX, SPAI, RCEL, OBIO, EDAP, ZJYL, NSPR, and HYPR

Should you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include Biosig Technologies (BSGM), Profound Medical (PROF), Pro-Dex (PDEX), Safe Pro Group (SPAI), Avita Medical (RCEL), Orchestra BioMed (OBIO), Edap Tms (EDAP), Jin Medical International (ZJYL), InspireMD (NSPR), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

CollPlant Biotechnologies vs. Its Competitors

Biosig Technologies (NASDAQ:BSGM) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

Biosig Technologies has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -541.34%. CollPlant Biotechnologies' return on equity of -94.08% beat Biosig Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Biosig TechnologiesN/A -5,336.99% -90.03%
CollPlant Biotechnologies -541.34%-94.08%-68.62%

In the previous week, CollPlant Biotechnologies had 2 more articles in the media than Biosig Technologies. MarketBeat recorded 4 mentions for CollPlant Biotechnologies and 2 mentions for Biosig Technologies. CollPlant Biotechnologies' average media sentiment score of 0.25 beat Biosig Technologies' score of 0.00 indicating that CollPlant Biotechnologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biosig Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CollPlant Biotechnologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Biosig Technologies presently has a consensus target price of $10.00, suggesting a potential upside of 57.60%. CollPlant Biotechnologies has a consensus target price of $11.50, suggesting a potential upside of 338.93%. Given CollPlant Biotechnologies' higher probable upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Biosig Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biosig Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
CollPlant Biotechnologies
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Biosig Technologies has higher earnings, but lower revenue than CollPlant Biotechnologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biosig Technologies$13K15,334.89-$10.33MN/AN/A
CollPlant Biotechnologies$510K65.35-$16.61M-$1.13-2.32

7.2% of Biosig Technologies shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 24.8% of Biosig Technologies shares are held by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Biosig Technologies has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500.

Summary

CollPlant Biotechnologies beats Biosig Technologies on 8 of the 13 factors compared between the two stocks.

Get CollPlant Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLGN vs. The Competition

MetricCollPlant BiotechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$32.82M$3.12B$5.74B$10.30B
Dividend YieldN/A2.37%5.86%4.62%
P/E Ratio-2.3221.0377.1026.52
Price / Sales65.35249.02451.8387.93
Price / CashN/A45.4837.2260.63
Price / Book2.229.5613.846.31
Net Income-$16.61M-$53.02M$3.29B$271.37M
7 Day Performance-3.32%-1.58%-0.75%0.57%
1 Month Performance-1.50%2.82%3.84%6.20%
1 Year Performance-45.02%9.34%84.93%28.33%

CollPlant Biotechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLGN
CollPlant Biotechnologies
2.816 of 5 stars
$2.62
+1.6%
$11.50
+338.9%
-46.0%$32.82M$510K-2.3270Analyst Forecast
Short Interest ↓
Gap Down
BSGM
Biosig Technologies
2.0939 of 5 stars
$4.12
+6.1%
$10.00
+143.0%
+1,962.7%$129.45M$40K0.0050News Coverage
Gap Down
PROF
Profound Medical
2.2121 of 5 stars
$4.08
-0.9%
$11.00
+169.9%
-48.3%$122.45M$10.68M-2.79150
PDEX
Pro-Dex
2.6571 of 5 stars
$37.05
+4.2%
$56.00
+51.1%
+32.1%$119.64M$66.59M13.59140Gap Up
SPAI
Safe Pro Group
3.3628 of 5 stars
$7.10
+10.2%
$10.50
+48.0%
+139.4%$112.68M$1.50M-8.7111Positive News
Upcoming Earnings
RCEL
Avita Medical
2.4607 of 5 stars
$4.20
-0.4%
$11.60
+176.5%
-43.1%$111.56M$64.25M-2.13130Analyst Forecast
Gap Up
OBIO
Orchestra BioMed
2.8156 of 5 stars
$2.72
-0.5%
$13.50
+397.2%
-47.9%$105.29M$2.64M-1.494Short Interest ↑
EDAP
Edap Tms
2.2668 of 5 stars
$2.72
-0.7%
$8.50
+212.5%
-23.8%$101.52M$63.02M-4.45230Gap Down
ZJYL
Jin Medical International
N/A$0.64
+2.0%
N/A-77.5%$100.66M$23.50M0.00245Short Interest ↑
Gap Up
NSPR
InspireMD
3.58 of 5 stars
$2.40
-0.2%
$4.50
+87.9%
-5.9%$99.92M$7.07M-3.1950News Coverage
Positive News
Gap Up
HYPR
Hyperfine
1.3426 of 5 stars
$1.23
+3.4%
$1.28
+4.3%
+41.0%$96.73M$12.89M-2.37190

Related Companies and Tools


This page (NASDAQ:CLGN) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners